Cargando…
A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
BACKGROUND: Severe hypoglycaemia still represents a significant problem in insulin-treated diabetes. Most patients do not experience severe hypoglycaemia often. However, 20% of patients with type 1 diabetes experience recurrent severe hypoglycaemia corresponding to at least two episodes per year. Th...
Autores principales: | Kristensen, Peter Lommer, Pedersen-Bjergaard, Ulrik, Beck-Nielsen, Henning, Nørgaard, Kirsten, Perrild, Hans, Christiansen, Jens Sandahl, Jensen, Tonny, Parving, Hans-Henrik, Thorsteinsson, Birger, Tarnow, Lise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433358/ https://www.ncbi.nlm.nih.gov/pubmed/22727048 http://dx.doi.org/10.1186/1472-6823-12-10 |
Ejemplares similares
-
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
por: Agesen, Rikke Mette, et al.
Publicado: (2019) -
Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open‐label, crossover trial
por: Pedersen‐Bjergaard, Ulrik, et al.
Publicado: (2021) -
Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
por: Kristensen, Peter L, et al.
Publicado: (2016) -
Insulin Hypoglycæmia
Publicado: (1948) -
Approach to assessing the economic impact of insulin‐related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool
por: Parekh, W. A., et al.
Publicado: (2015)